Shaolin Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Shaolin Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-128,274	Closed	-$9.07K	–	277
2024 Q3	$9.07K	Hold	128,274	–	–	﹤0.01%	221
2024 Q2	$11.2K	Hold	128,274	–	–	﹤0.01%	277
2024 Q1	$20.5K	Sell	128,274 -35,241	-22%	-$4K	﹤0.01%	237
2023 Q4	$13.2K	Sell	163,515 -2,000	-1%	-$270	﹤0.01%	322
2023 Q3	$65K	Buy	+165,515	New	+$63.8K	﹤0.01%	284
2023 Q2	–	Sell	-65,849	Closed	-$11.6K	–	741
2023 Q1	$9K	Buy	65,849 +15,171	+30%	+$2.16K	﹤0.01%	635
2022 Q4	$4K	Hold	50,678	–	–	﹤0.01%	728
2022 Q3	$8K	Hold	50,678	–	–	﹤0.01%	849
2022 Q2	$13K	Hold	50,678	–	–	﹤0.01%	889
2022 Q1	$31K	Hold	50,678	–	–	﹤0.01%	841
2021 Q4	$70K	Hold	50,678	–	–	﹤0.01%	679
2021 Q3	$70K	Buy	+50,678	New	+$63.3K	﹤0.01%	525

Other funds holding NKGNW

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Shaolin Capital Management's NKGNW Position: Q4 2024 in Review

Shaolin Capital Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2024, closing a stake of 128,274 shares — an estimated $9.07K sold.

Shaolin Capital Management first reported a position in NKGNW in Q3 2021 and held it in 12 quarters. The position peaked at $70K in Q4 2021. 26 funds tracked by Wall St. Rank hold NKGNW as of Q4 2024.

Shaolin Capital Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2024 after selling out during the quarter.
Shaolin Capital Management sold 128,274 NKGen Biotech, Inc. Warrants shares in Q4 2024, an estimated $9.07K.
Shaolin Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 12 quarters.
Shaolin Capital Management's NKGen Biotech, Inc. Warrants position peaked at $70K in Q4 2021.
26 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2024.

Based on Shaolin Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.